[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-01-27-5":3},{"date":4,"filings":5,"has_more":110,"limit":111,"page":112,"total_count":113},"2026-01-27",[6,14,21,24,32,36,43,47,54,60,64,71,76,83,89,96,100,107],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Sudarshan Colorants India Ltd","2026-01-27T09:49:25.587000","BSE","Company Clarifies Recent Stock Price Movement","69783d248e61c963d6d0a923","HEUBACHIND","• Company responded to BSE\u002FSEBI query dated January 23, 2026 regarding significant price movements in its shares\n• Confirmed all necessary disclosures have been made in a timely and transparent manner as required by SEBI regulations\n• Stated it is not aware of any undisclosed price-sensitive information that requires disclosure\n• Attributed share price movements entirely to market conditions beyond company control",{"company_name":15,"filing_date":16,"filing_source":9,"headline":17,"id":18,"stock_code":19,"summary_text":20},"Shree Digvijay Cement Company Ltd","2026-01-27T09:39:25.424000","Board Meeting Scheduled for Q3 FY2026 Financial Results Review","69783acc199dcd549585df11","SHREDIGCEM","• Board meeting to be held on Friday, February 6, 2026, to consider and approve unaudited standalone & consolidated financial results for Q3 and nine months ending December 31, 2025\n• Trading window remains closed from January 1, 2026, until February 8, 2026 (both days inclusive)\n• Investors can access additional information on the company website: www.digvijaycement.com",{"company_name":15,"filing_date":16,"filing_source":9,"headline":17,"id":22,"stock_code":19,"summary_text":23},"69783acceef3895f5b9dfca2","• Board of Directors meeting scheduled for Friday, February 6, 2026\n• Meeting will consider and approve unaudited standalone & consolidated financial results for Q3 and nine months ending December 31, 2025\n• Trading window remains closed from January 1, 2026 until February 8, 2026 (both days inclusive)",{"company_name":25,"filing_date":26,"filing_source":27,"headline":28,"id":29,"stock_code":30,"summary_text":31},"Emerald Tyre Manufacturers Limited","2026-01-27T09:24:27.268000","NSE","ETML Acquires African Manufacturing Base for Global Expansion","69783747199dcd549585df0a","ETML","• ETML has acquired a manufacturing facility in Africa (specific country not disclosed)\n• The acquisition will serve as a core driver for ETML's Africa strategy and export operations\n• The facility will function as an export launchpad specifically targeting the US market\n• Strategic advantages include access to deep industrial & mining ecosystem in the region\n• Location offers efficient logistics, port infrastructure, and seamless access to global trade corridors\n• The move positions ETML to expand across high-growth African industrial and mining tyre segments\n• The acquisition leverages the positive economic climate in the region for scalable international operations",{"company_name":25,"filing_date":26,"filing_source":27,"headline":33,"id":34,"stock_code":30,"summary_text":35},"Emerald Tyre Announces Strategic Acquisition for African Expansion","697837471e9e72baba85b636","• Emerald Tyre Manufacturing Limited (ETML) has acquired a manufacturing base in Africa\n• Acquisition will serve as the core driver of ETML's Africa and export strategy\n• The facility will anchor the company's expansion across high-growth African industrial and mining tyre segments\n• Will also function as Emerald Tyre's export launchpad for the US Market\n• Strategic advantages include access to deep industrial & mining ecosystem, efficient logistics and port infrastructure\n• Acquisition leverages seamless access to global trade corridors in a positive economic climate",{"company_name":37,"filing_date":38,"filing_source":9,"headline":39,"id":40,"stock_code":41,"summary_text":42},"Jonjua Overseas Ltd","2026-01-27T09:24:25.418000","Board Approves 5:40 Bonus Share Issuance","69783749eef3895f5b9dfc9c","542446","• Company has approved allotment of 30,30,844 fully paid-up bonus equity shares\n• Bonus ratio: 5 shares for every 40 shares held by shareholders\n• Record date fixed as January 23, 2026\n• Each bonus share has face value of Rs. 10\u002F- each\n• Paid-up share capital increases from Rs. 24.24 crores to Rs. 27.27 crores\n• Total equity shares increase from 2,42,46,753 to 2,72,77,597 shares",{"company_name":37,"filing_date":38,"filing_source":9,"headline":44,"id":45,"stock_code":41,"summary_text":46},"Bonus Share Allotment in Ratio of 5:40 Approved","697837490c576f69cb66865b","• Board has approved allotment of 30,30,844 bonus equity shares of Rs. 10\u002F- each\n• Bonus ratio: 5 shares for every 40 shares held by shareholders\n• Record date fixed as January 23, 2026\n• Paid-up share capital increases from Rs. 24.24 crores to Rs. 27.27 crores\n• Total equity shares increase from 2,42,46,753 to 2,72,77,597 shares",{"company_name":48,"filing_date":49,"filing_source":27,"headline":50,"id":51,"stock_code":52,"summary_text":53},"Wockhardt Limited","2026-01-27T09:09:26.817000","Wockhardt's Fifth Novel Antibiotic Matches Gold-Standard in Phase 3 Trial","697833c58e61c963d6d0a910","WOCKPHARMA","• Foviscu® (WCK 4282) successfully matched meropenem with 93.23% clinical cure rate in pivotal Phase 3 trial\n• Demonstrates effectiveness against resistant ESBL-producing pathogens causing difficult-to-treat infections\n• Represents significant milestone in Wockhardt's 25+ year drug discovery program focused on multi-drug resistant infections\n• Adds to company's portfolio of 6 products with USFDA Qualified Infectious Disease Product status\n• Positions Wockhardt for potential future regulatory approvals and commercialization opportunities",{"company_name":55,"filing_date":56,"filing_source":9,"headline":57,"id":58,"stock_code":52,"summary_text":59},"Wockhardt Ltd","2026-01-27T09:04:25.383000","Wockhardt's Fifth Novel Antibiotic Achieves Milestone in Phase 3 Trial","69783298184ef8f2159dd3d9","• Foviscu® (WCK 4282) successfully matched gold-standard meropenem in pivotal Phase 3 clinical trial\n• Achieved 93.23% clinical cure rate vs 92.31% with meropenem in treating complicated infections\n• Demonstrates effectiveness against resistant bacteria as first-line therapies increasingly fail\n• Represents significant advancement in Wockhardt's portfolio of 6 novel antibiotics with USFDA QIDP status\n• Positions company for future growth in the critical antimicrobial resistance market",{"company_name":55,"filing_date":56,"filing_source":9,"headline":61,"id":62,"stock_code":52,"summary_text":63},"Wockhardt's Fifth Novel Antibiotic, Foviscu® (WCK 4282), Matches Gold-Standard Meropenem in Pivotal Phase 3 Trial","697832981e9e72baba85b632","• Foviscu® (WCK 4282) successfully demonstrated efficacy equivalent to gold-standard antibiotic meropenem in Phase 3 clinical trials\n• The novel antibiotic shows strong activity against ESBL-producing pathogens, addressing rising antimicrobial resistance\n• Product has received Qualified Infectious Disease Product (QIDP) designation from the US FDA\n• Development was partly supported by India's National Biopharma Mission (NBM)\n• Represents the fifth novel antibiotic in Wockhardt's portfolio of 6 anti-bacterial products with QIDP status",{"company_name":65,"filing_date":66,"filing_source":9,"headline":67,"id":68,"stock_code":69,"summary_text":70},"Sundaram Brake Linings Ltd","2026-01-27T08:59:25.220000","Board Meeting Scheduled for Q3 FY2025-26 Financial Results","6978316a0c576f69cb66864c","590072","• Board of Directors meeting scheduled for February 6, 2026 to consider and approve unaudited financial results for Q3 and nine months ended December 31, 2025\n• Trading window for company scrips remains closed from January 1 to February 8, 2026 for Promoters, Directors, and Designated Employees\n• Closure complies with SEBI regulations and company's Code of Conduct to prevent insider trading",{"company_name":25,"filing_date":72,"filing_source":27,"headline":73,"id":74,"stock_code":30,"summary_text":75},"2026-01-27T08:54:26.804000","Emerald Tyre to Acquire 65% Stake in South African Tyre Company","6978305d199dcd549585defa","• Indian manufacturer Emerald Tyre plans to acquire majority stake (65%) in an unnamed South African tyre company\n• Strategic acquisition aims to expand Emerald's volumes in the US market\n• South Africa will serve as a core driver of ETML's Africa strategy and export launchpad\n• Target company offers ready manufacturing base and diverse customer base across industrial segments\n• Acquisition leverages South Africa's structural advantages: deep industrial ecosystem, efficient logistics, port infrastructure, and access to global trade corridors\n• Move positions Emerald for expansion across high-growth African industrial and mining tyre segments",{"company_name":77,"filing_date":78,"filing_source":9,"headline":79,"id":80,"stock_code":81,"summary_text":82},"Mukka Proteins Ltd","2026-01-27T08:54:25.533000","Mukka Proteins Strengthens Carbon Credit Portfolio with Verra-Listed BSF Project and Approved Capacity Expansion","697830401e9e72baba85b62f","MUKKA","• Company has received Verra certification for its Black Soldier Fly (BSF) project, enhancing its environmental credentials\n• Capacity expansion has been officially approved, signaling growth in production capabilities\n• These developments position the company for improved sustainability metrics and potential new revenue streams\n• The carbon credit portfolio strengthening aligns with global ESG trends and may create additional value beyond core operations",{"company_name":84,"filing_date":85,"filing_source":27,"headline":67,"id":86,"stock_code":87,"summary_text":88},"Sundaram Brake Linings Limited","2026-01-27T08:49:27.118000","69782ed38e61c963d6d0a8fe","SUNDRMBRAK","• Board meeting scheduled for February 6, 2026 to consider and approve Q3 FY2025-26 unaudited standalone financial results\n• Trading window closure in effect from January 1, 2026 until February 8, 2026 for insiders\n• Quarterly financial results will be for the period ended December 2025",{"company_name":90,"filing_date":91,"filing_source":9,"headline":92,"id":93,"stock_code":94,"summary_text":95},"Aadhar Housing Finance Ltd","2026-01-27T08:49:25.253000","LTI Announces Acquisition of Majority Stake","69782f4feef3895f5b9dfc80","AADHARHFC","* Acquirer to purchase 54.33% stake from the Seller, potentially increasing to 80.15% through an open offer\n* Transaction valued at ₹469.97 per share plus ₹2.71 interest per share\n* Total consideration could reach ₹53.66 billion (~$640 million) if fully subscribed\n* Open offer to acquire up to 25.82% from public shareholders\n* Post-acquisition, Acquirer aims to hold between 65.02% and 81.24% of the expanded voting share capital\n* Seller will retain no more than 9.99% stake post-transaction",{"company_name":90,"filing_date":91,"filing_source":9,"headline":97,"id":98,"stock_code":94,"summary_text":99},"Major Acquisition Announced: Acquirer to Purchase 65.02% Stake in Target Company","69782f4f199dcd549585def1","• Acquirer is purchasing 23,88,89,392 equity shares (54.33% of expanded voting share capital) from the Seller\n• Making a mandatory open offer to public shareholders for up to 11,35,25,761 shares (25.82%)\n• Offer price is ₹469.97 per share plus ₹2.71 interest per share\n• Total consideration for the open offer could reach ₹53.66 billion (~$650 million) if fully subscribed\n• Transaction will give Acquirer control of the Target Company\n• Post-acquisition, Acquirer could own up to 81.24% of the company\n• No intention to delist the Target Company following the acquisition",{"company_name":101,"filing_date":102,"filing_source":27,"headline":103,"id":104,"stock_code":105,"summary_text":106},"AXISCADES Technologies Limited","2026-01-27T08:34:27.374000","Contact Information Update for Investor Queries","69782b94eef3895f5b9dfc78","AXISCADES","• Updated contact details provided for AXISCADES Technologies Ltd. investor relations\n• Contact information includes representatives from AXISCADES, OGMA (Embraer Group), and MUFG Intime India\n• Key contacts include Mr. Akash Pandey (Investor Relations) and Mr. Ravikumar Joghee (Chief Strategy & Marketing Officer)\n• Media inquiries directed to Shreeya Namjoshi\n• Document includes standard Safe Harbor statement regarding forward-looking statements",{"company_name":101,"filing_date":102,"filing_source":27,"headline":103,"id":108,"stock_code":105,"summary_text":109},"69782b94199dcd549585dee7","• Updated contact details provided for AXISCADES Technologies Ltd., OGMA, and MUFG Intime India\n• Key contacts include Mr. Akash Pandey (Investor Relations) and Mr. Ravikumar Joghee (Chief Strategy & Marketing Officer) at AXISCADES\n• OGMA (part of Embraer Group) contact: Mr. Nuno Coutinho (Head of Institutional Affairs)\n• MUFG Intime India Pvt Ltd serves as investor relations partner\n• Media\u002FPR inquiries directed to Shreeya Namjoshi",false,100,5,418]